Center for Autoimmunity and Inflammation
The Center’s declared goal is on new treatments that teach the immune system to tolerate the body’s own cells.
The Center’s declared goal is on new treatments that teach the immune system to tolerate the body’s own cells.
The Center is at the forefront of exploring new and sometimes unexpected avenues for novel immune-based cancer treatments.
Amid the COVID-19 pandemic, LJI infectious disease experts quickly mobilized a task force to respond to the current crisis.
Our focus is immunology, because we believe that no other biomedical discipline has greater implications for human health than immunology. By unraveling the complexities of the immune system, LJI researchers are directly tackling an extraordinarily diverse array of diseases, which together account for more than two-thirds of all deaths in the U.S. each year. Such diseases include type 1 diabetes, cancer, COVID-19, rheumatoid arthritis, multiple sclerosis, asthma, allergies, influenza, dengue fever and many other illnesses.